Rivera-Romero, OctavioAtterbury, AbigailBanerjee, IndraneelCochet, SolennKapoor, Ritika R.Mathew, VerghesePerge, KevinShah, PratikTollerfield, SallyTrouvin, Marie-AgatheKoledova, EkaterinaKeiser, Matthew2025-07-162025-07-162025-050926-96301879-8365https://hdl.handle.net/11441/175357Assessing healthcare professionals’ (HCPs’) perceptions on the appropriateness, ease of use and reliability of connected digital health technologies can help to understand acceptance and their recommendations to patients/caregivers for personalization of growth hormone (GH) therapy. Two study cases representing different versions of a digital device were used to facilitate expert panel discussions in the UK and France involving 19 paediatric HCPs. Panel members commented that the new functionalities embodied user-friendly technological progression. The evolution of the easypod device should sustain clinical decision support and enhance personalized approaches to care and management of patients receiving GH therapy.application/pdf2 p.engAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/Digital healthGrowth disordersGrowth hormoneTechnologyinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccesshttps://doi.org/10.3233/SHTI250610